Mingkui Zhou

Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.

Shiu-Lok Hu, M. Robert-Guroff, D. Forthal, 2014, Vaccine.

Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice.

U. Dietrich, B. Brill, M. Sakarellos-Daitsiotis, 2012, Vaccine.

Inhibition of HIV‐1 Entry: Multiple Keys to Close the Door

U. Dietrich, Mingkui Zhou, Maria Hertje, 2010, ChemMedChem.

Are anti-HIV IgAs good guys or bad guys?

R. Ruprecht, Mingkui Zhou, 2014, Retrovirology.

Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge.

Q. Sattentau, J. Heeney, R. Weiss, 2015, Vaccine.

Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants

M. Humbert, D. Montefiori, A. Griffiths, 2019, Journal of Virology.

Identification of a new epitope for HIV‐neutralizing antibodies in the gp41 membrane proximal external region by an Env‐tailored phage display library

U. Dietrich, J. Koch, J. Benito, 2013, European journal of immunology.